top of page
The Opportunity
Solving an Unmet Need
One Platform
Addressing the mechanism across multiple indications
Zero
Approved drug therapies that reverse it
300M+
People affected by arterial calcification worldwide
Why Now
01
Growing recognition in cardiovascular medicine that vascular stiffening is a primary driver of morbidity and cost
02
Increasing investor and pharma interest in mechanism-driven longevity strategies built on structural biology
03
Scalable platforms commanding premium valuations over single-asset risk profiles
Stay informed.
Receive updates on scientific milestones, partnerships, and company news.
Newsletter only. Unsubscribe at any time. Privacy Policy
bottom of page